- Home
- ALZN vs AMBO Comparison
ALZN vs AMBO Comparison
Compare ALZN & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- AMBO
- Stock Information
- Founded
- ALZN 2016
- AMBO 2000
- Country
- ALZN United States
- AMBO United States
- Employees
- ALZN N/A
- AMBO N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- AMBO Other Consumer Services
- Sector
- ALZN Health Care
- AMBO Real Estate
- Exchange
- ALZN Nasdaq
- AMBO Nasdaq
- Market Cap
- ALZN 6.1M
- AMBO 7.1M
- IPO Year
- ALZN 2021
- AMBO 2010
- Fundamental
- Price
- ALZN $0.70
- AMBO $2.56
- Analyst Decision
- ALZN Strong Buy
- AMBO
- Analyst Count
- ALZN 1
- AMBO 0
- Target Price
- ALZN $20.00
- AMBO N/A
- AVG Volume (30 Days)
- ALZN 124.9K
- AMBO 11.6K
- Earning Date
- ALZN 03-10-2025
- AMBO 12-30-2024
- Dividend Yield
- ALZN N/A
- AMBO N/A
- EPS Growth
- ALZN N/A
- AMBO N/A
- EPS
- ALZN N/A
- AMBO 0.11
- Revenue
- ALZN N/A
- AMBO $9,392,000.00
- Revenue This Year
- ALZN $322.64
- AMBO N/A
- Revenue Next Year
- ALZN N/A
- AMBO N/A
- P/E Ratio
- ALZN N/A
- AMBO $23.56
- Revenue Growth
- ALZN N/A
- AMBO 2.50
- 52 Week Low
- ALZN $0.64
- AMBO $1.00
- 52 Week High
- ALZN $15.06
- AMBO $5.55
- Technical
- Relative Strength Index (RSI)
- ALZN 35.54
- AMBO 47.49
- Support Level
- ALZN $0.67
- AMBO $2.45
- Resistance Level
- ALZN $0.71
- AMBO $3.14
- Average True Range (ATR)
- ALZN 0.07
- AMBO 0.30
- MACD
- ALZN -0.02
- AMBO -0.02
- Stochastic Oscillator
- ALZN 10.43
- AMBO 19.86
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.